RXST Insider Trading Activity and SEC Form 4 Filings
RXST insider trading summary
Over the past 12 months, insiders at RxSight, Inc. (RXST) reported 4 sales worth $118K by 4 insiders and no open-market purchases on SEC Form 4. Net insider selling was $118K.
Latest RXST insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 2, 2026 | Mark Wilterding | Chief Financial Officer | Sell | $54K (7,765 @ $6.96) |
| Sep 2, 2026 | Eric Weinberg | See remarks | Sell | $14K (2,041 @ $6.96) |
| Sep 2, 2026 | Ilya Goldshleger | Chief Operating Officer | Sell | $14K (2,041 @ $6.96) |
| Sep 2, 2026 | Ronald M MD Kurtz | Chief Medical Officer | Sell | $35K (5,100 @ $6.96) |
| Mar 12, 2025 | Tamara Fountain | Insider | Sell | $180K (7,000 @ $25.71) |
| Jan 22, 2025 | Shweta Maniar | Insider | Sell | $109K (3,519 @ $30.87) |
| Jan 16, 2025 | Jesse Anderson Corley | Insider | Buy | $55K (1,767 @ $31.13) |
| Jan 15, 2025 | Jesse Anderson Corley | Insider | Buy | $45K (1,443 @ $31.18) |
| Nov 29, 2024 | Ilya Goldshleger | See remarks | Sell | $143K (3,105 @ $46.08) |
| Nov 26, 2024 | Shweta Maniar | Insider | Sell | $174K (3,782 @ $45.88) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.